Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.12 is 843% above its 3-year average of 0.12, near the high end of its 3-year range (0.00–1.12).
As of the fiscal period ended Tuesday, June 30, 2026. 105.44% above its 12-month average of 0.54.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.12.
CURRENT RATIO
1.12
CURRENT RATIO AVG TTM
0.54
CURRENT RATIO AVG 3Y
0.12
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+105.44%
CURRENT VS 3Y AVG
+843.42%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.58
median of 762 covered companies
CURRENT VS SECTOR MEDIAN
-68.83%
vs the sector median at left
Liminatus Pharma, Inc. Class A Common Stock
Market Cap
$5.23M
Current Ratio
1.12
TTM Avg
0.54
3Y Avg
0.12
5Y Avg
N/A
Market Cap
$5.20M
Current Ratio
1.88
TTM Avg
1.74
3Y Avg
1.99
5Y Avg
1.99
Market Cap
$5.23M
Current Ratio
0.09
TTM Avg
0.18
3Y Avg
0.44
5Y Avg
0.97
Market Cap
$5.29M
Current Ratio
1.44
TTM Avg
1.10
3Y Avg
1.11
5Y Avg
1.95
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | $5.23M | 1.12 | 0.54 | 0.12 | N/A |
| Lunai Bioworks Inc. (LNAI)vs › | $5.21M | 0.19 | 0.06 | 0.46 | 2.58 |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.20M | 1.88 | 1.74 | 1.99 | 1.99 |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.23M | 0.09 | 0.18 | 0.44 | 0.97 |
| Pulmatrix, Inc. (PULM)vs › | $5.41M | 4.70 | 11.62 | 9.04 | 8.74 |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.29M | 1.44 | 1.10 | 1.11 | 1.95 |
| Alzamend Neuro Inc (ALZN)vs › | $5.29M | 3.01 | 3.95 | 2.52 | 4.28 |
| Soligenix, Inc. (SNGX)vs › | $5.34M | 2.77 | 2.10 | 1.65 | 2.34 |
| Imunon, Inc. (IMNN)vs › | $5.02M | 1.82 | 1.99 | 2.53 | 3.43 |
| CalciMedica, Inc. (CALC)vs › | $4.94M | 5.58 | 4.46 | 3.04 | 7.15 |
Current Ratio
1.12
Quick Ratio
1.12
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.12 |
| 2026-03-31 | 0.96 |
| 2025-12-31 | 0.05 |
| 2025-09-30 | 0.42 |
| 2025-06-30 | 0.17 |
| 2025-03-31 | 0.00 |
| 2024-12-31 | 0.09 |
| 2024-09-30 | 0.05 |
| 2024-06-30 | 0.06 |
| 2024-03-31 | 0.22 |
| 2023-12-31 | 0.04 |
| 2023-09-30 | 0.08 |
